Swiss Group for Clinical Cancer Research
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1965-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sakk.ch/
Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 46
- Registration Number
- NCT00030810
- Locations
- 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 232
- Registration Number
- NCT00030771
- Locations
- 🇩🇪
Klinikum der Stadt Mannheim, Mannheim, Germany
🇨🇭Kantonsspital Baden, Baden, Switzerland
🇩🇪Klinik Loewenstein gGmbH, Löwenstein, Germany
Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 319
- Registration Number
- NCT00030732
- Locations
- 🇮🇱
Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
🇮🇹Istituto Nazionale per lo Studio e la Cura dei Tumori, Naples, Italy
🇨🇭Kantonspital Aarau, Aarau, Switzerland
Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 86
- Registration Number
- NCT00004208
- Locations
- 🇨🇭
Universitaetsspital-Basel, Basel, Switzerland
Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 61
- Registration Number
- NCT00030745
- Locations
- 🇨🇭
UniversitaetsSpital, Zurich, Switzerland
© Copyright 2024. All Rights Reserved by MedPath